Early hospital-at-home pilot studies were promising but small. Several years into broader adoption enabled by the CMS waiver program, health systems and researchers now have larger, longer-running datasets to evaluate — and the accumulating evidence base is giving a clearer, more nuanced picture of where the model genuinely delivers and where questions remain.
Mortality and Complication Rates
Multiple published studies comparing hospital-at-home to matched traditional inpatient cohorts for the same qualifying diagnoses have found comparable or lower mortality rates in the home-based cohort, along with consistently lower rates of hospital-acquired complications — delirium, falls, and healthcare-associated infections in particular, which occur less frequently when a patient isn't in a shared inpatient environment. These findings have held up reasonably consistently across multiple health systems and study designs, lending credibility to the model's core safety claim.
Readmission Rates
Thirty-day readmission rates — a closely tracked quality and cost metric across the healthcare system — have generally been comparable between hospital-at-home and traditional inpatient care in published studies, with some programs reporting modestly lower readmission rates, potentially reflecting the more intensive post-discharge follow-up structure many hospital-at-home programs build in as standard practice, rather than treating discharge as a hard endpoint.
Cost Comparisons
Cost analyses have generally found hospital-at-home care costs less than equivalent traditional inpatient stays, driven primarily by lower facility overhead costs, though the magnitude of savings varies considerably by study and health system, and some of the reported savings reflect avoided costs (shorter length of stay, fewer complications) rather than simply cheaper delivery of the same care. From a health system perspective, the current Medicare waiver reimburses hospital-at-home at standard inpatient rates, meaning the cost savings currently accrue primarily to the health system rather than being passed through as lower charges — a dynamic that may shift if reimbursement policy evolves toward the actual lower cost of delivery.
Patient Experience and Satisfaction
Patient-reported experience measures have consistently favored hospital-at-home over traditional inpatient care across published program evaluations, with patients citing comfort of the home environment, better sleep, more control over their daily routine, and reduced disruption to family life as key drivers of higher satisfaction. Family and caregiver satisfaction has also generally scored favorably, though caregiver burden — the actual demands placed on family members supporting a hospital-at-home patient — remains a less thoroughly studied dimension of the model's real-world impact.
Where the Evidence Base Still Has Gaps
Most published hospital-at-home outcomes research to date comes from academic medical centers and larger health systems with substantial resources to build robust programs, raising open questions about whether outcomes generalize to smaller or rural health systems with fewer resources to invest in the command-center infrastructure and rapid-response capability the model depends on. Longer-term outcomes data — six-month and one-year measures beyond the immediate episode of care — also remains more limited than the substantial body of 30-day outcome data now available.
Conclusion
The accumulating multi-year evidence base for hospital-at-home has generally reinforced the model's early promise: comparable or better clinical outcomes, meaningfully lower complication rates, and consistently higher patient satisfaction. As the evidence matures, the central remaining question is less whether the model works clinically and more how sustainably it can scale beyond the well-resourced health systems that pioneered it.
